4.8 Article

An endogenous caspase-11 ligand elicits interleukin-1 release from living dendritic cells

Journal

SCIENCE
Volume 352, Issue 6290, Pages 1232-1236

Publisher

AMER ASSOC ADVANCEMENT SCIENCE
DOI: 10.1126/science.aaf3036

Keywords

-

Funding

  1. NIH [AI093589, AI072955, P30 DK34854, 1R15HL121770-01A1, 1R01AI121066-01A1]
  2. Burroughs Wellcome Fund
  3. Harvard Digestive Diseases Center [P30 DK34854]
  4. Cariplo Foundation
  5. Jane Coffin Childs Fund

Ask authors/readers for more resources

Dendritic cells (DCs) use pattern recognition receptors to detect microorganisms and activate protective immunity. These cells and receptors are thought to operate in an all-or-nothing manner, existing in an immunologically active or inactive state. Here, we report that encounters with microbial products and self-encoded oxidized phospholipids (oxPAPC) induce an enhanced DC activation state, which we call hyperactive. Hyperactive DCs induce potent adaptive immune responses and are elicited by caspase-11, an enzyme that binds oxPAPC and bacterial lipopolysaccharide (LPS). oxPAPC and LPS bind caspase-11 via distinct domains and elicit different inflammasome-dependent activities. Both lipids induce caspase-11-dependent interleukin-1 release, but only LPS induces pyroptosis. The cells and receptors of the innate immune system can therefore achieve different activation states, which may permit context-dependent responses to infection.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available